Reference 22 - Bioequivalence safety and tolerability of imatinib tablets compared with capsules

NonrulemakingSupporting & Related MaterialFDA-2026-P-6541-0024
🔔 Subscribe
Document

Details

The document's own metadata, straight from regulations.gov.

Posted
Jun 9, 2026
Agency
Food and Drug Administration (FDA)
© 2026 Government Context · not affiliated with any U.S. government agencyPrivacyTermsDockets